Nevanac Suspension

Chronic Noninfectious Uveitis Treatment

Full Spectrum Imaging Device

Self-Retaining Bicanalicular Stent

Stepped Probes

Contact Lenses for Refractive Ametropia

Nevanac Suspension

The FDA has approved Alcon’s new drug application for Nevanac suspension (nepafenac 0.1 percent ophthalmic suspension). Nevanac suspension is indicated for the treatment of pain and inflammation associated with cataract surgery.

According to Alcon, this prodrug is converted intraocularly into amfenac. It rapidly penetrates ocular tissues while minimizing surface accumulation and potentially reducing the risk of ocular surface complications.

Alcon, Inc.
800-757-9195 or 817-293-0450
www.alconinc.com

Chronic Noninfectious Uveitis Treatment

Bausch & Lomb received FDA approval for Retisert (fluocinolone acetonide intravitreal implant) 0.59 milligrams. Retisert is a single-indication orphan drug for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye.

Retisert consists of a tiny drug reservoir designed to deliver sustained levels of fluocinolone acetonide directly to the back of the eye for approximately 2 1/2 years.

Bausch & Lomb
800-227-1427 or 585-338-6000
www.bausch.com

Full Spectrum Imaging Device

Carl Zeiss Meditec has introduced the Visucam Lite to capture digital images of the retina and posterior segment of the eye for diagnosis and documentation of retinal diseases and glaucoma.

Visucam Lite electronically captures and displays photographs of the retina. It offers color, red-free and fluorescein angiography as standard still-capture modes, along with a black-and-white video capture mode.

The Visucam Lite conforms to the Digital Imaging and Communications in Medicine (DICOM) standard and is capable of exporting images in a variety of formats via a practice’s network or the accompanying CD burner.

Carl Zeiss Meditec
877-486-7473 or 925-557-4100
www.meditec.zeiss.com

Self-Retaining Bicanalicular Stent

FCI Ophthalmics received FDA approval for its Self-Retaining Bicanaliculus Intubation Set (SRS). Primary indications include horizontal lacrimal duct stricture and punctal stenosis.

The SRS, designed by Pierre Bigé, MD, allows the physician to intubate the canaliculi when using topical anesthetic drops. The stent is made of medical-grade silicone and is available in three lengths, 25-, 30- and 35-millimeters. (Disposable sizers sold separately.)

An anchor-shaped head at each end of the stent provides fixation. Each head consists of two flexible winglets that fold inward during insertion through the punctum and spread back out after passage through the junction of the common canaliculus and lacrimal sac, securing the stent in place.

A centrally placed marking on the tube acts as a reference point, allowing verification of proper stent positioning following insertion. The winglets fold backward for easy removal of the stent from the ducts.

FCI Ophthalmics
800-932-4202 or 781-826-9060
www.fci-ophthalmics.com

Stepped Probes

Iridex has added two Iris Medical Stepped EndoProbe hand pieces to its line of disposable endophotocoagulation probes. They are the 20-24 gauge, 45-degree angle and the 25-30 gauge, 45-degree angle Stepped EndoProbe models.

Both probes offer a tapered needle, allowing the angled tip to be inserted through either standard 20- or 25-gauge cannulas for full coverage of the peripheral retina. The hand pieces offer a rigid, fixed-angle alternative to flexible tip directional probes.

They work with Iridex’s Iris Medical laser photocoagulators, as well as competitive laser systems that accept a universal SubMinature version A (SMA) connector.

Iridex Corp.
800-388-9087 or 650-962-8100
www.iridex.com

Contact Lenses for Refractive Ametropia

The FDA has approved the Bausch & Lomb PureVision Toric contact lens for vision correction in people with astigmatism up to 5 D.

The lens is made from a silicone hydrogel material called balafilcon A, and is indicated for the correction of refractive ametropia.

The PureVision Toric lens is designed for monthly replacement and is approved for either daily wear or up to 30 days of continuous wear.
 
Bausch & Lomb
800-828-9030 or 585-338-6000
www.bausch.com